objeCtives: To evaluate the management of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in a referral hospital by assessing clinical variables, patientreported outcomes and caregivers' burden. Methods: An observational, retrospective study was conducted. All patients (aged > 18 years) attending the specialised unit on CTEPH at the 12 de Octubre Hospital (Spain), between January 2010 and November 2012, were offered to participate. Clinical variables were recorded at the clinical session for treatment decision (Pulmonary endarterectomy -PEA-if operability was confirmed or medication therapy -MT-if inoperable), and after one year. Outcomes considered: The New York Heart Association Functional Class (FC), 6-Minute Walking Distance, pulmonary arterial pressure, pulmonary vascular resistance and pro-brain natriuretic peptide. Participants completed the EQ-5D and caregivers' fulfilled the Zarit Burden Interview. Differences between groups were studied (Chi-squared, Mann-Whitney U and ANCOVA). Results: A total of 64 CTEPH cases (57.8% males) were included. Mean (SD) age at diagnosis was 55.8 (14.9) and 67.2% had an III-IV FC at diagnosis. At the moment of treatment prescription, differences in clinical variables were not found (all p> 0.4) between PEA (n= 35-54.7%-) and MT groups (n= 29-45.3%-). After 12 months, 8 patients died (2 in PEA group and 6 in MT). Among survivors, FC was significantly better in PEA group (93.9% improved at least one level). Regarding EQ-5D, patients undergoing PEA showed significant higher utilities (0.83-0.17-vs. 0.53-0.31-p= 0.007) and VAS values (80.22-14.24-vs. 49.47-20.68-p< 0.001). Furthermore, mean VAS values in PEA group were comparable to general population (adjusted by sex and age). Finally, formal care was needed by just 4.8% of patients in PEA versus 33.3% in MT. Reported caregivers' burden were relatively low in both groups (p= 0.87). ConClusions: The positive outcomes obtained, especially in those patients undergoing PEA, suggest the experienced management of CTEPH by this referral hospital and highlights the importance of detecting candidates for PEA. PCV22 the 3.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.